TITO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 150
AS - Asia 101
EU - Europa 62
SA - Sud America 4
Totale 317
Nazione #
US - Stati Uniti d'America 150
JP - Giappone 41
CN - Cina 22
SG - Singapore 20
IT - Italia 18
IE - Irlanda 10
SE - Svezia 7
UA - Ucraina 7
AT - Austria 6
VN - Vietnam 6
IN - India 5
DE - Germania 4
ID - Indonesia 4
GB - Regno Unito 3
BR - Brasile 2
FR - Francia 2
PL - Polonia 2
AR - Argentina 1
ES - Italia 1
HK - Hong Kong 1
KR - Corea 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
VE - Venezuela 1
Totale 317
Città #
Tokyo 39
Santa Clara 29
Chandler 21
Dublin 10
Beijing 9
Fairfield 9
Singapore 9
Cambridge 8
Ashburn 7
Dong Ket 6
Houston 6
Vienna 6
Medford 5
Nyköping 5
Seattle 5
Wilmington 5
Woodbridge 5
Jacksonville 4
Turin 4
Ann Arbor 3
Chennai 3
Princeton 3
San Diego 3
Columbus 2
Dearborn 2
Guangzhou 2
Hangzhou 2
Jakarta 2
Lomazzo 2
Pisa 2
Shenyang 2
Torino 2
Warsaw 2
Bucharest 1
Buenos Aires 1
Caracas 1
Chesterfield 1
Florence 1
Fortaleza 1
Fremont 1
Hong Kong 1
Kiel 1
Moscow 1
Nanjing 1
Nashville 1
Nuremberg 1
Redwood City 1
Samatan 1
San Mateo 1
Seoul 1
Shanghai 1
Shenzhen 1
Silver Spring 1
Somerville 1
São Paulo 1
Thrissur 1
Totale 247
Nome #
Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study 158
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 99
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia 67
Totale 324
Categoria #
all - tutte 1.012
article - articoli 0
book - libri 0
conference - conferenze 324
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 0 0 0 11 8 2 3
2020/202166 1 4 8 6 11 7 8 2 5 4 4 6
2021/202236 2 3 1 2 1 2 1 3 0 4 9 8
2022/202347 6 11 1 2 2 17 4 0 1 1 2 0
2023/202462 0 8 0 1 0 42 0 2 0 5 1 3
2024/202568 3 2 4 2 27 10 4 6 10 0 0 0
Totale 324